As investment $$$ pour into digital health projects, the scope and scale of tech giants' ambitions in health become ever clearer. From drug discovery and clinical research to patient monitoring and disease management, tech giants are leveraging the latest advances in artificial intelligence (AI), deep learning, analytics and wearable technology to drive innovation and disrupt processes. How can pharma respond and what strengths does it have that tech companies need?
This expert report draws on the insights of 15 digital health experts in pharma, consulting and tech companies to give a unique and comprehensive analysis of the current and future digital health landscape and the role tech companies will play.
Discover on this page…
Why this report is important to you
What the report will enable you to do
Full Report Contents
Why this report is important to you
Global technology giants are the most valuable companies on the Standard and Poor's 500 Index, and they are making big bets in healthcare. These companies' technologies and consumer expertise are poised to transform an industry ripe for disruption through telemedicine, data mobility, cloud computing, wearables, artificial intelligence, big data and the empowered consumer/patient. In contrast to the fast moving digital sector, the risk adverse and heavily regulated pharma industry is looking out of time and place. Can pharma change its slow, legacy culture; adopt new technologies for efficiency; work collaboratively across silos, and attract the best talent? Pharma needs to collaborate with tech companies as much as tech companies need pharma's unique set of skills. There are opportunities a plenty for those companies wishing to embrace change.
With focus on…
This report will enable you to…
Understand the drivers of tech giant expansion into health and identify where their interests lay
Know what digital technologies will most benefit pharma, and why
Appreciate how demanding tech savvy patients are changing the healthcare landscape
Play to your drug development, regulatory, production, marketing and market access strengths when partnering with tech companies
Compete effectively with tech companies for digital, analytical and AI talent
Challenge and replace slow moving siloed corporate structures that are not fit for purpose in a digital world
Know where digital health is most likely to disrupt pharma's operations and respond with progressive strategies
Research objectives and methodology
The digital transformation of health
Digital health trends and funding
Tech giants lead the global economy, making big bets in healthcare
What is driving technology giants' expansion into digital health and life sciences?
What digital health areas are being targeted by tech giants?
Are big tech companies vying for the same opportunities?
Is any tech company poised to become a dominant force in digital health?
Tech giants' activities in healthcare and life sciences
Who are the tech companies' healthcare customers?
Consumers in the digital health transformation
Consumer trust in tech companies
Digitally-savvy millennials moving up the ranks of healthcare
Engaging an ageing population in digital health
Tech-enabled consumers reordering the healthcare landscape
The evolving role of the patient
Tech giants changing the healthcare landscape
How are tech giants changing the healthcare landscape?
How might these changes affect key healthcare stakeholders?
Opportunities for pharma in a health landscape driven by tech company innovation
Are tech giants looking to advance their own initiatives or form partnerships?
Partnering for success
What threats does a bigger tech presence in healthcare pose for the pharma industry?
In what areas are tech companies at a disadvantage in digital health?
What's holding pharma back in the digital health transformation?
Regulatory and policy changes
Regulatory challenges tech companies face
FDA PreCert pilot programme for software developers
What is the reaction to the FDA PreCert programme?
Talent trends: competing in science and technology
Tech giant hiring trends
Pharma competing for digital, analytical and AI talent
Artificial Intelligence (AI) and the future of drug discovery
Understanding AI and its subsectors
Tech giants' AI leaders remain tied to academia
Future opportunities for AI-led technologies in healthcare and pharma
Competing with tech giants for AI technology
The next five years
How will tech companies change the delivery of healthcare?
Where is the future value for pharma in partnering with tech companies?
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook